user:
userid:
representing:

Application title 

The title of the application should describe the proposed new or changed listing. Provide an application title that is meaningful for you/your organisation when drafting it in the HPP. 

 

Is this a resubmission of a previous application? 

If you have applied to list on the Prescribed List for the same product previously, you will need to provide the previous application number, if known. If you are resubmitted within the HPP (from the Applications page) then this will be pre-filled for you. 

 

Are you applying to Part A, Part B or Part C of the Prescribed List? 

If you select Part A of the Prescribed List, you will be asked: 

 

What is the pathway for this application? 

When selecting the pathway for your application, please refer to the Prescribed List Guide. You can select from: 

  • Tier 1 – Departmental assessment pathway 
  • Tier 2 - Clinical HTA pathway 
  • Tier 3 - Full HTA pathway 

Applications falling into the Tier 3 pathway will either be novel devices, or co-dependent applications dependent on a new or changed MBS Item. Tier 3 applications require applicants to first apply to MSAC.  

 

If Tier 3 is selected, you will be asked: 

Does this product employ novel technologies? 

Please refer to the PL Guide for information on the definition of a product employing novel technologies. 

 

Does your product rely on the listing of a new Medicare Benefits Schedule (MBS) item? 

This question will determine if the application is co-dependent on an MSAC application. 

 

Have you lodged an MSAC application for this product? 

If you select ‘Yes’ you will be required to search for and select the relevant lodged MSAC application.  

If you select ‘No’, the following text will be displayed: 

You will be prevented from lodging this Tier 3 application until you have lodged your MSAC application. Lodge your MSAC application from the Applications page. 

 

What is the nature of this application? 

 

A new product or product system on the Prescribed List 

 

An amendment to an existing Billing code(s) on the Prescribed List 

 

An expansion of a single product to multiple products on the Prescribed List (only available for selection for Tier 1 and Tier 2 applications) 

 

A compression of multiple products into a single product on the Prescribed List (only available for selection for Tier 1 and Tier 2 applications) 

 

 If you select Part B of the Prescribed List, you will be asked: 

 What is the nature of this application? 

 

A new product or product system on the Prescribed List 

 

An amendment to an existing Billing code(s) on the Prescribed List 

 

Benefit update ​​​​​​

 

If you select Part C of the Prescribed List, you will be asked: 

What is the pathway for this application? 

When selecting the pathway for your application, please refer to the Prescribed List Guide. For a part C application you can select from: 

  • Tier 2 - Clinical HTA pathway 

  • Tier 3 - Full HTA pathway 

Applications falling into the Tier 3 pathway will either be novel devices, or co-dependent applications dependent on a new or changed MBS Item. Tier 3 applications require applicants to first apply to MSAC.  

 

If Tier 3 is selected, you will be asked: 

Does this product employ novel technologies? 

Please refer to the PL Guide for information on the definition of a product employing novel technologies. 

 

Does your product rely on the listing of a new Medicare Benefits Scheme (MBS) item? 

This question will determine if the application is co-dependent on an MSAC application. 

 

Have you lodged an MSAC application for this product? 

If you select ‘Yes’ you will be required to search for and select the relevant lodged MSAC application.  

If you select ‘No’, the following text will be displayed: 

You will be prevented from lodging this Tier 3 application until you have lodged your MSAC application. Lodge your MSAC application from the Applications page. 

 

What is the nature of this application? 

 

A new product or product system on the Prescribed List 

 

An amendment to an existing Billing code(s) on the Prescribed List 

 

An expansion of a single product to multiple products on the Prescribed List (only available for selection for Tier 1 and Tier 2 applications) 

 

A compression of multiple products into a single product on the Prescribed List (only available for selection for Tier 1 and Tier 2 applications) 

 

 

Keywords: User Support

Last Updated: 24 September, 2024